What if we told you: You have the power to change childhood cancer diagnosis and treatment as we know it?


Watch HERE as Jeff tells you how…

Give now to change childhood cancer:

Give now


The Jeff Gordon Children’s Foundation is partnering with Memorial Sloan Kettering Cancer Center (MSK) in New York to extend an incredible technology called IMPACT™ to children fighting cancer.

IMPACT™ is a genetic test invented at MSK that analyzes the full sequence of all known cancer genes. The test results not only guide more precise treatment, but also open the door to proven, targeted-therapy drugs that have not yet been considered for a young person. The result is more successful treatment with far less toxic side effects.

The test already exists. We need your help providing it to kids who need it. With your help, children with cancer all across America will have access to this lifesaving test. Any doctor – in any small town or big city – can send a sample to MSK for IMPACT™ testing, and those results can bring new hope to kids facing cancer. You can bring new hope to kids facing cancer. $1,800 is the average cost to provide this lifesaving test for one child.

The Jeff Gordon Pediatric IMPACT™ Initiative at MSK is a fund that will provide as many children as possible with IMPACT™ testing. Every donation, in any amount, gets us closer to testing more kids and giving them the opportunity for better treatment.


Story of survivorship: Emily Jones

Emily Jones

Ten days before her 4th birthday, Emily Jones was diagnosed with advanced-stage kidney cancer. Her treatment plan, co-authored by medical teams at Children’s Medical Center of Dallas and MSK, included 8 surgeries, 5 months of chemotherapy, 6 days of radiation, and countless hours in a hospital all before Emily turned 6 years old. But, in Emily’s case, it paid off. Almost 10 years later, Emily is an energetic, bright, and happy eighth-grader. But for many more kids, the best treatment plan remains unclear. With your help, the Jeff Gordon Pediatric IMPACT™ Initiative at MSK can unlock many more less toxic, more effective cures.


Jeff Gordon with Dr. Andrew Kung

About Memorial Sloan Kettering Cancer Center

As the world’s oldest and largest private cancer center, MSK is uniquely equipped to care for children, adolescents, and young adults with all types of cancer, from the most common to the most rare. The MSK pediatric cancer program is the largest of its kind in the United States and offers leading-edge treatment options.

MSK Cancer Center logo and Dr. Andrew Kung

About Dr. Andrew Kung

Andrew Kung, MD, PhD, is a physician-scientist in pediatric hematology-oncology and Chair of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center. He oversees the clinical, research, and educational missions of the department. Dr. Kung’s clinical expertise is in caring for patients using cancer genomics, precision oncology, and stem cell transplantation. His research program extends leading-edge technologies to identify the causes of pediatric cancer and develop better, less toxic treatments.

Genetic sequencing

Save

Save

Save

Save

Save

Save

Save

Save